PGF-0025_Journal_sprdA_m8.indd

First Page		Document Content
Nephrology Macrolides Antifungals Tacrolimus Kidney transplantation Immunosuppressive drug Voriconazole Azathioprine Nephrotoxicity Medicine Immunosuppressants Organ transplants		PGF-0025_Journal_sprdA_m8.indd Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 250,79 KB Share Document on Facebook

	AZATHIOPRINE / 6-MERCAPTOPURINE TREATMENT FOR IBD PATIENTS INFORMATION SHEET This information leaflet is designed to answer common questions patients ask about their medicine. Further information can be found in the in DocID: 1qAnH - View Document
	Microsoft PowerPoint - PhilNat-ClinImmunmodulation2016 handout [Kompatibilitätsmodus] DocID: 1ogX3 - View Document
	In renal transplant patients at high-immunologic risk • Rapamune and Cyclosporine Combination Therapy (for the first 12 months post-transplantation): One loading dose of up to 15 mg on day 1, followed by daily mainten DocID: 1lhSD - View Document
	Dermatology Issue 6 t 2008 Optimised Treatment in Atopic Dermatitis – An Update and Outlook Treatment success factors – what makes a difference? DocID: 1fL0g - View Document
	Malaria Journal BioMed Central Open Access DocID: 1aYXj - View Document